FDA Clears Restella Reconstructive BioScaffolds for Reconstructive Surgery

TELA Bio Inc announces its Restella Reconstructive BioScaffolds have been awarded 510(k) clearance from the US Food and Drug Administration for implantation to reinforce soft tissue where weakness exists in patients requiring soft tissue repair or reinforcement in plastic and reconstructive procedures.